| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.
|
Nat Genet
|
2010
|
8.48
|
|
2
|
Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis.
|
Nat Genet
|
2010
|
2.56
|
|
3
|
Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis.
|
Eur J Immunol
|
2005
|
1.96
|
|
4
|
Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force.
|
Ann Rheum Dis
|
2013
|
1.74
|
|
5
|
Consensus on a core set of domains for psoriatic arthritis.
|
J Rheumatol
|
2007
|
1.60
|
|
6
|
Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies.
|
Arthritis Res Ther
|
2009
|
1.28
|
|
7
|
Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis.
|
J Rheumatol
|
2010
|
1.17
|
|
8
|
Reduction of synovial sublining layer inflammation and proinflammatory cytokine expression in psoriatic arthritis treated with methotrexate.
|
Arthritis Rheum
|
2004
|
1.12
|
|
9
|
Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers.
|
J Rheumatol
|
2009
|
1.08
|
|
10
|
Remission in psoriatic arthritis: is it possible and how can it be predicted?
|
Arthritis Res Ther
|
2010
|
1.06
|
|
11
|
Outcome measures in psoriatic arthritis.
|
J Rheumatol
|
2007
|
1.05
|
|
12
|
Synovial macrophages as a biomarker of response to therapeutic intervention in rheumatoid arthritis: standardization and consistency across centers.
|
J Rheumatol
|
2007
|
1.02
|
|
13
|
Reappraisal of OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage endpoints in rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: the OMERACT 9 v2 criteria.
|
J Rheumatol
|
2009
|
1.00
|
|
14
|
Resolution of endothelial activation and down-regulation of Tie2 receptor in psoriatic skin after infliximab therapy.
|
J Am Acad Dermatol
|
2006
|
0.95
|
|
15
|
Quantitation of metalloproteinase gene expression in rheumatoid and psoriatic arthritis synovial tissue distal and proximal to the cartilage-pannus junction.
|
J Rheumatol
|
2004
|
0.93
|
|
16
|
Development of composite measures for psoriatic arthritis: a report from the GRAPPA 2010 annual meeting.
|
J Rheumatol
|
2012
|
0.92
|
|
17
|
Variants in RUNX3 contribute to susceptibility to psoriatic arthritis, exhibiting further common ground with ankylosing spondylitis.
|
Arthritis Rheum
|
2013
|
0.91
|
|
18
|
Proposal for levels of evidence schema for validation of a soluble biomarker reflecting damage endpoints in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, and recommendations for study design.
|
J Rheumatol
|
2009
|
0.91
|
|
19
|
Corticotropin-releasing hormone signaling in synovial tissue vascular endothelium is mediated through the cAMP/CREB pathway.
|
Ann N Y Acad Sci
|
2002
|
0.90
|
|
20
|
Glycosylation status of serum in inflammatory arthritis in response to anti-TNF treatment.
|
Rheumatology (Oxford)
|
2013
|
0.89
|
|
21
|
Vitamin D and its emerging role in immunopathology.
|
Clin Rheumatol
|
2011
|
0.89
|
|
22
|
Clues to the pathogenesis of psoriasis and psoriatic arthritis from imaging: a literature review.
|
J Rheumatol
|
2008
|
0.87
|
|
23
|
Filaggrin null alleles are not associated with psoriasis.
|
J Invest Dermatol
|
2007
|
0.86
|
|
24
|
Quality of life, social support, and knowledge of disease in women with rheumatoid arthritis.
|
Arthritis Rheum
|
2003
|
0.84
|
|
25
|
Composite measures in psoriatic arthritis: GRAPPA 2008.
|
J Rheumatol
|
2010
|
0.84
|
|
26
|
Rheumatic disease differentiation using immunoglobulin G sugar printing by high density electrophoresis.
|
J Rheumatol
|
2003
|
0.82
|
|
27
|
Constitutional trisomy 8 and Behçet syndrome.
|
Am J Med Genet A
|
2009
|
0.82
|
|
28
|
Interleukin 15 primes natural killer cells to kill via NKG2D and cPLA2 and this pathway is active in psoriatic arthritis.
|
PLoS One
|
2013
|
0.82
|
|
29
|
Testing of the OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage in rheumatoid arthritis: a systematic literature search on 5 candidate biomarkers.
|
J Rheumatol
|
2009
|
0.82
|
|
30
|
Periarticular bone gain at proximal interphalangeal joints and changes in bone turnover markers in response to tumor necrosis factor inhibitors in rheumatoid and psoriatic arthritis.
|
J Rheumatol
|
2013
|
0.82
|
|
31
|
Pathogenetic overview of psoriatic disease.
|
J Rheumatol Suppl
|
2012
|
0.80
|
|
32
|
Tumor necrosis factor inhibition modulates thrombospondin-1 expression in human inflammatory joint disease through altered NR4A2 activity.
|
Am J Pathol
|
2013
|
0.80
|
|
33
|
A role for type 1alpha corticotropin-releasing hormone receptors in mediating local changes in chronically inflamed tissue.
|
Am J Pathol
|
2007
|
0.79
|
|
34
|
Imaging in psoriasis and psoriatic arthritis: GRAPPA 2008.
|
J Rheumatol
|
2010
|
0.78
|
|
35
|
Exercise and manual physiotherapy arthritis research trial (EMPART): a multicentre randomised controlled trial.
|
BMC Musculoskelet Disord
|
2009
|
0.78
|
|
36
|
Biomarkers in psoriasis and psoriatic arthritis: GRAPPA 2008.
|
J Rheumatol
|
2010
|
0.77
|
|
37
|
Fatigue is an independent outcome measure and is sensitive to change in patients with psoriatic arthritis.
|
Clin Exp Rheumatol
|
2010
|
0.77
|
|
38
|
Serum levels of tissue inhibitor of metalloproteinase-1 and periarticular bone loss in early rheumatoid arthritis.
|
Clin Rheumatol
|
2008
|
0.77
|
|
39
|
Biological biomarkers in psoriatic disease. A review.
|
J Rheumatol
|
2008
|
0.77
|
|
40
|
GRAPPA Responder Index Project (GRACE): a report from the GRAPPA 2011 annual meeting.
|
J Rheumatol
|
2012
|
0.76
|
|
41
|
Composite Measures in Psoriatic Arthritis: a report from the GRAPPA 2009 annual meeting.
|
J Rheumatol
|
2011
|
0.76
|
|
42
|
Corticosteroid-associated osteonecrosis of the femoral head: complete resolution on MRI with conservative treatment.
|
BMJ Case Rep
|
2009
|
0.75
|
|
43
|
Immunohistochemistry of the inflamed synovium.
|
Methods Mol Med
|
2007
|
0.75
|
|
44
|
Pulmonary fibrosis in systemic sclerosis: association with myocardial fibrosis.
|
J Thorac Imaging
|
2012
|
0.75
|
|
45
|
Clinical image: keratitis in reactive arthritis.
|
Arthritis Rheum
|
2011
|
0.75
|
|
46
|
The path forward to biomarker discovery in psoriatic disease: a report from the GRAPPA 2010 annual meeting.
|
J Rheumatol
|
2012
|
0.75
|